Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase

T Yamauchi1, K Ueki, K Tobe

  • 1Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Endocrine Journal
|October 28, 1998
PubMed

Insights

Growth hormone (GH) signaling activates MAP kinase through epidermal growth factor receptor (EGFR) phosphorylation by JAK2. This novel pathway reveals EGFR acts as a docking protein, independent of its kinase activity, for GH-induced gene expression.

Area of Science:

  • Endocrinology and Signal Transduction
  • Molecular Cell Biology

Background:

  • Growth hormone (GH) receptor activation initiates intracellular signaling cascades, including JAK2-STAT and MAP kinase pathways, mediating GH's biological effects.
  • The precise mechanisms by which GH activates MAP kinases, particularly involving Grb2 and Shc, remain incompletely understood, contrasting with receptor tyrosine kinase pathways.

Purpose of the Study:

  • To elucidate the role of epidermal growth factor receptor (EGFR) in GH-induced mitogen-activated protein (MAP) kinase activation and gene expression.
  • To investigate the involvement of Janus kinase 2 (JAK2) in the phosphorylation and activation of EGFR within the GH signaling pathway.

Main Methods:

  • Stimulation of GH receptor signaling in liver tissue and cell lines (CHO-GHR cells) to assess EGFR tyrosine phosphorylation and Grb2 association.
  • Expression of wild-type and mutant EGFR in CHO-GHR cells to determine the necessity of EGFR tyrosine phosphorylation sites and kinase activity for MAP kinase activation.
  • Utilized dominant-negative JAK2 and in vitro kinase assays to identify JAK2 as the kinase responsible for EGFR phosphorylation at specific sites.

Main Results:

  • GH stimulation induced tyrosine phosphorylation of EGFR and its association with Grb2, leading to increased MAP kinase activity in liver.
  • GH-induced MAP kinase activation and c-fos expression were dependent on EGFR tyrosine phosphorylation sites but not its intrinsic kinase activity.
  • JAK2 was identified as the key kinase phosphorylating EGFR at tyrosine 1068, facilitating Grb2 binding and subsequent MAP kinase activation.

Conclusions:

  • EGFR functions as a docking protein in GH signaling, becoming phosphorylated by JAK2 to recruit Grb2 and activate MAP kinases, independent of EGFR's own kinase function.
  • This study reveals a novel cross-talk mechanism where a cytokine receptor superfamily member (GH receptor) signals through an associated non-receptor tyrosine kinase (JAK2) to phosphorylate and utilize a growth factor receptor (EGFR) for signal transduction.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...